Skip to content
OpenCapital
AI Tools
Earnings
Screener
Charts
Watchlist
Pricing
Connect your AI
Get started
Toggle navigation menu
NTH
NTHI
NTHI
Debt-to-equity
Debt-to-equity at other companies
Bristol-Myers Squibb
BMY
2.2×
-0.6×
Pfizer
PFE
0.7×
0.0×
Merck & Co.
MRK
1.1×
+0.3×
Oric Pharmaceuticals, Inc.
ORIC
0×
0.0×
Nuvation Bio
NUVB
0.2×
+0.2×
Crinetics Pharmaceuticals
CRNX
0×
0.0×
Other financials
Income statement
See full
Revenue
$40.0K
-7.0%
Operating income
-$7.1M
+77.9%
Net income
-$8.8M
+72.7%
EPS (diluted)
-$0.38
+78.7%
Balance sheet
See full
Cash & equivalents
$138.6K
-97.5%
Total debt
$666.1K
—
Total equity
-$13.2M
-37.5%
Total assets
$3.3M
-60.6%
Cash flow
See full
Operating cash flow
-$7.0M
-23.7%
CapEx
$125.0K
—
Free cash flow
-$5.2M
—
Valuation
See full
Market cap
$114.62M
+51.0%
Enterprise value
$115.15M
+51.1%
P/S
1,432.9×
—
Profitability
See full
Operating margin
-46,870.7%
—
Net margin
-51,613.3%
—
FCF margin
-26,083.2%
—
Returns & leverage
See full
Return on equity
338.1%
—
Current ratio
0.1×
-0.3×